Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
出版年份 2019 全文链接
标题
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
作者
关键词
Hepatocellular carcinoma, Circulating cell-free DNA, Sorafenib, Biomarker, Genome-wide copy number alteration, Vascular endothelial growth factor-a
出版物
BMC CANCER
Volume 19, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-04-01
DOI
10.1186/s12885-019-5483-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Abstract 3138: Changes in tumor cell-free DNA copy number instability (CNI) predict therapeutic response in metastatic cancers
- (2016) Glen J. Weiss et al. CANCER RESEARCH
- Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer
- (2016) Louise Carter et al. NATURE MEDICINE
- A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers
- (2015) B. T. Li et al. ANNALS OF ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab
- (2014) Karina Dahl Steffensen et al. EUROPEAN JOURNAL OF CANCER
- Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
- (2014) E. Horwitz et al. Cancer Discovery
- VEGFA Genomic Amplification Tailors Treatment of HCCs with Sorafenib
- (2014) X. Luo et al. Cancer Discovery
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma
- (2013) Kai Wang et al. HEPATOLOGY
- Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
- (2013) François-Clément Bidard et al. INTERNATIONAL JOURNAL OF CANCER
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Pan-cancer patterns of somatic copy number alteration
- (2013) Travis I Zack et al. NATURE GENETICS
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients
- (2012) António E. Pinto et al. ANNALS OF SURGICAL ONCOLOGY
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes
- (2012) T.-M. Kim et al. GENOME RESEARCH
- Summarizing and correcting the GC content bias in high-throughput sequencing
- (2012) Yuval Benjamini et al. NUCLEIC ACIDS RESEARCH
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
- (2012) R. J. Leary et al. Science Translational Medicine
- Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma
- (2010) Chian-Feng Chen et al. HEPATOLOGY
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started